The 6-minute walk test, motor function measure and quantitative thigh muscle MRI in Becker muscular dystrophy: A cross-sectional study

被引:36
|
作者
Fischer, Dirk [1 ,2 ,3 ]
Hafner, Patricia [1 ,2 ]
Rubino, Daniela [1 ]
Schmid, Maurice [1 ]
Neuhaus, Cornelia [4 ]
Jung, Hans [5 ,6 ]
Bieri, Oliver [7 ]
Haas, Tanja [7 ]
Gloor, Monika [7 ]
Fischmann, Arne [8 ,9 ]
Bonati, Ulrike [1 ]
机构
[1] Univ Basel, Childrens Hosp, Div Neuropaediat, Basel, Switzerland
[2] Kantonsspital Baselland, Univ Clin Internal Med, Bruderholz, Switzerland
[3] Univ Basel Hosp, Dept Neurol, Basel, Switzerland
[4] Univ Basel, Childrens Hosp, Therapy Dept, Basel, Switzerland
[5] Univ Hosp, Dept Neurol, Zurich, Switzerland
[6] Univ Zurich, CH-8006 Zurich, Switzerland
[7] Univ Basel Hosp, Dept Radiol, Div Radiol Phys, Basel, Switzerland
[8] Univ Basel Hosp, Inst Radiol, Div Neuroradiol, Basel, Switzerland
[9] Hirslanden Klin St Anna, Luzern, Switzerland
关键词
Imaging biomarker; Dystrophinopathy; Becker muscular dystrophy; Quantitative MR; Timed function tests; OUTCOME MEASURE; DIXON; FAT; REPRODUCIBILITY; INFILTRATION; WATER; GENE;
D O I
10.1016/j.nmd.2016.04.009
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Becker muscular dystrophy (BMD) has an incidence of 1 in 16 000 male births. This cross-sectional study investigated the relation between validated functional scores and quantitative MRI (qMRI) of thigh muscles in 20 ambulatory BMD patients, aged 18.3-60 years (mean 31.2; SD 11.1). Clinical assessments included the motor function measure (MFM) and its subscales, as well as timed function tests such as the 6-minute walk test (6MWT) and the timed 10-m run/walk test. Quantitative MRI of the thigh muscles included the mean fat fraction (MFF) using a 2-point Dixon (2-PD) technique, and transverse relaxation time (T2) measurements. The mean MFM value was 80.4%, SD 9.44 and the D1 subscore 54.5%, SD 19.9. The median 6MWT was 195m, IQR 160-330.2. The median 10-m run/walk test was 7.4 seconds, IQR 6.1-9.3. The mean fat fraction of the thigh muscles was 55.6%, SD 17.4%, mean T2 relaxation times of all muscles: 69.9 ms, SD 14.4. The flexors had the highest MFF and T2 relaxation times, followed by the extensors and the adductors. MFF and global T2 relaxation times were highly negatively correlated with the MFM total, Dl-subscore and 6MWT, and positively correlated with the 10 m run/walk test time (p < 0.01). Age was not correlated with MIT, global T2 relaxation time or clinical assessments. Both MFF and T2 measures in the thigh muscle were well correlated with clinical function in BMD and may serve as a surrogate outcome measure in clinical trials. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:414 / 422
页数:9
相关论文
共 50 条
  • [21] Quantitative Muscle MRI as Outcome Measure in Patients With Becker Muscular Dystrophy-A 1-Year Follow-Up Study
    Sheikh, Aisha M.
    Rudolf, Karen
    Witting, Nanna
    Vissing, John
    [J]. FRONTIERS IN NEUROLOGY, 2021, 11
  • [22] Cross-sectional analysis of 6-minute walk distance and diastolic function in a Hong Kong cohort of community-living older adults
    Yang, X.
    Lui, L. T.
    Li, Q.
    Cheng, K. F.
    Liu, S.
    Yau, F.
    Sahota, D.
    Fan, Y.
    Lee, A. P. W.
    Woo, J.
    Fung, E.
    [J]. EUROPEAN HEART JOURNAL, 2020, 41 : 37 - 37
  • [23] The 6 min walk test (6MWT) as a clinical trial outcome measure in Duchenne/Becker Muscular Dystrophy (DMD/BMD)
    McDonald, C. M.
    Henricson, E. K.
    Han, J. J.
    Nicorici, A. R.
    Abresch, R. T.
    Atkinson, L. A.
    Reha, A. L.
    Elfring, G. L.
    Miller, L. L.
    [J]. NEUROMUSCULAR DISORDERS, 2008, 18 (9-10) : 739 - 739
  • [24] THE 6-MINUTE WALK TEST AND OTHER ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: LONGITUDINAL NATURAL HISTORY OBSERVATIONS OVER 48 WEEKS FROM A MULTICENTER STUDY
    Mcdonald, Craig M.
    Henricson, Erik K.
    Abresch, R. Ted
    Florence, Julaine M.
    Eagle, Michelle
    Gappmaier, Eduard
    Glanzman, Allan M.
    Spiegel, Robert
    Barth, Jay
    Elfring, Gary
    Reha, Allen
    Peltz, Stuart
    [J]. MUSCLE & NERVE, 2013, 48 (03) : 343 - 356
  • [25] The Correlation of Health-Related Quality of Life with Cystic Fibrosis Severity Markers in Chest CT Scan and 6-Minute Walk Test: A Cross-Sectional Study
    Mohammadreza Modaresi
    Zahra Roshanzamir
    Rohola Shirzadi
    [J]. Indian Journal of Pediatrics, 2022, 89 : 113 - 117
  • [26] Effect of walkway length and turning direction on the distance covered in the 6-minute walk test among adults over 50 years of age: a cross-sectional study
    Ng, Shamay S.
    Yu, Phoebe C.
    To, Fenny P.
    Chung, Josiben S.
    Cheung, Tracy H.
    [J]. PHYSIOTHERAPY, 2013, 99 (01) : 63 - 70
  • [27] Energy Cost During the 6-Minute Walk Test and Its Relationship to Real-World Walking After Stroke: A Correlational, Cross-Sectional Pilot Study
    Ribeiro, Jean A. M.
    Oliveira, Simone G.
    Di Thommazo-Luporini, Luciana
    Monteiro, Clara, I
    Phillips, Shane A.
    Catai, Aparecida M.
    Borghi-Silva, Audrey
    Russo, Thiago L.
    [J]. PHYSICAL THERAPY, 2019, 99 (12): : 1656 - 1666
  • [28] The Correlation of Health-Related Quality of Life with Cystic Fibrosis Severity Markers in Chest CT Scan and 6-Minute Walk Test: A Cross-Sectional Study
    Modaresi, Mohammadreza
    Roshanzamir, Zahra
    Shirzadi, Rohola
    [J]. INDIAN JOURNAL OF PEDIATRICS, 2022, 89 (02): : 113 - 117
  • [29] Validity of the 6 minute walking test in myotonic dystrophy type 1 in a large scale cross-sectional study
    Moat, D.
    Jimenez-Moreno, C.
    Mayhew, A.
    Massey, C.
    Nikolenko, N.
    Turner, C.
    Lochmuller, H.
    [J]. NEUROMUSCULAR DISORDERS, 2017, 27 : S226 - S227
  • [30] THE 6-MINUTE WALK TEST AND OTHER CLINICAL ENDPOINTS IN DUCHENNE MUSCULAR DYSTROPHY: RELIABILITY, CONCURRENT VALIDITY, AND MINIMAL CLINICALLY IMPORTANT DIFFERENCES FROM A MULTICENTER STUDY
    McDonald, Craig M.
    Henricson, Erik K.
    Abresch, R. Ted
    Florence, Julaine
    Eagle, Michelle
    Gappmaier, Eduard
    Glanzman, Allan M.
    Spiegel, Robert
    Barth, Jay
    Elfring, Gary
    Reha, Allen
    Peltz, Stuart W.
    [J]. MUSCLE & NERVE, 2013, 48 (03) : 357 - 368